Sarah M. Schwarzenböck

1.6k total citations
42 papers, 771 citations indexed

About

Sarah M. Schwarzenböck is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Sarah M. Schwarzenböck has authored 42 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 23 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Oncology. Recurrent topics in Sarah M. Schwarzenböck's work include Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Medical Imaging Techniques and Applications (13 papers). Sarah M. Schwarzenböck is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Medical Imaging Techniques and Applications (13 papers). Sarah M. Schwarzenböck collaborates with scholars based in Germany, United States and Switzerland. Sarah M. Schwarzenböck's co-authors include Bernd J. Krause, Jens Kurth, Michael Souvatzoglou, Martin Heuschkel, Oliver W. Hakenberg, Markus Schwaiger, Michael Schäfers, Kambiz Rahbar, Lars Stegger and Margitta Retz and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Urology.

In The Last Decade

Sarah M. Schwarzenböck

42 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah M. Schwarzenböck Germany 17 473 411 215 88 74 42 771
Mehran Jamali United States 12 396 0.8× 298 0.7× 246 1.1× 67 0.8× 109 1.5× 21 703
Wolfgang Roll Germany 15 436 0.9× 261 0.6× 197 0.9× 81 0.9× 64 0.9× 46 737
Don Wilson Canada 17 413 0.9× 359 0.9× 279 1.3× 179 2.0× 95 1.3× 59 997
Johannes Schwenck Germany 14 398 0.8× 296 0.7× 173 0.8× 56 0.6× 122 1.6× 35 794
Christoph Straube Germany 17 251 0.5× 316 0.8× 136 0.6× 174 2.0× 47 0.6× 41 729
Kaisa Lehtiö Finland 11 566 1.2× 260 0.6× 170 0.8× 70 0.8× 80 1.1× 15 797
A. Fernandes United States 13 157 0.3× 294 0.7× 207 1.0× 98 1.1× 175 2.4× 23 679
Vanessa Drendel Germany 19 427 0.9× 821 2.0× 178 0.8× 63 0.7× 164 2.2× 33 1.1k
Hani Ashamalla United States 17 322 0.7× 371 0.9× 276 1.3× 70 0.8× 196 2.6× 70 1.0k
Jawana M. Lawhorn‐Crews United States 8 859 1.8× 349 0.8× 283 1.3× 67 0.8× 152 2.1× 17 1.2k

Countries citing papers authored by Sarah M. Schwarzenböck

Since Specialization
Citations

This map shows the geographic impact of Sarah M. Schwarzenböck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah M. Schwarzenböck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah M. Schwarzenböck more than expected).

Fields of papers citing papers by Sarah M. Schwarzenböck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah M. Schwarzenböck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah M. Schwarzenböck. The network helps show where Sarah M. Schwarzenböck may publish in the future.

Co-authorship network of co-authors of Sarah M. Schwarzenböck

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah M. Schwarzenböck. A scholar is included among the top collaborators of Sarah M. Schwarzenböck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah M. Schwarzenböck. Sarah M. Schwarzenböck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amsberg, Gunhild von, et al.. (2025). First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 66(6). 896–899. 3 indexed citations
2.
Holzgreve, Adrien, D. Hellwig, Henryk Barthel, et al.. (2025). PET imaging utilization and trends in Germany: a comprehensive survey. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4390–4398. 1 indexed citations
3.
Kurth, Jens, Surachet Imlimthan, Euy Sung Moon, et al.. (2023). Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3202–3213. 7 indexed citations
4.
Schlemmer, Heinz‐Peter, Bernd J. Krause, Viktoria Schütz, et al.. (2021). Imaging of prostate cancer. Deutsches Ärzteblatt international. 118(42). 713–719. 8 indexed citations
5.
Schwarzenböck, Sarah M., et al.. (2020). FDG PET Hybrid Imaging. Recent results in cancer research. 216. 625–667. 20 indexed citations
6.
Lindner, Tobias, Jan Stenzel, Alexander Höhn, et al.. (2020). Anatomical MRI and [18F]FDG PET/CT imaging of Schistosoma mansoni in a NMRI mouse model. Scientific Reports. 10(1). 17343–17343. 2 indexed citations
7.
Schwarzenböck, Sarah M. & Valentina Garibotto. (2020). Highlights of the 32th Annual Congress of the EANM, Barcelona 2019: the nucleolympic games of nuclear medicine—a global competition for excellence. European Journal of Nuclear Medicine and Molecular Imaging. 47(8). 1808–1819. 4 indexed citations
8.
Zanoni, Lucia, Cristina Nanni, Stefano Fanti, et al.. (2018). Prostate cancer imaging and therapy. 2 indexed citations
9.
Rohde, Sarah L., Falko Lange, Alexander Höhn, et al.. (2018). Antifibrogenic effects of vitamin D derivatives on mouse pancreatic stellate cells. World Journal of Gastroenterology. 24(2). 170–178. 20 indexed citations
10.
Kurth, Jens, Bernd J. Krause, Sarah M. Schwarzenböck, et al.. (2018). External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies. EJNMMI Research. 8(1). 32–32. 60 indexed citations
11.
Fanti, Stefano, Silvia Minozzi, Joshua James Morigi, et al.. (2017). Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions. European Journal of Nuclear Medicine and Molecular Imaging. 44(10). 1622–1635. 88 indexed citations
12.
Schmid, Sebastian C., Anuja Sathe, Ferdinand Guerth, et al.. (2017). Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin. Urologic Oncology Seminars and Original Investigations. 35(9). 544.e1–544.e10. 18 indexed citations
13.
Hakenberg, Oliver W., Martin Heuschkel, Désirée Louisê Dräger, et al.. (2016). Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging. Journal of Nuclear Medicine. 57(Supplement 3). 38S–42S. 24 indexed citations
14.
Schwarzenböck, Sarah M., Michael Souvatzoglou, Jens Kurth, et al.. (2016). [11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy. Oncotarget. 7(39). 63747–63757. 5 indexed citations
15.
Schwarzenböck, Sarah M., Jens Kurth, Michael Souvatzoglou, et al.. (2015). Comparison of [11C]Choline ([11C]CHO) and [18F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model. Molecular Imaging and Biology. 18(3). 393–401. 4 indexed citations
16.
Lange, Catharina, Jens Kurth, Anita Seese, et al.. (2015). Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy. European Radiology. 25(9). 2709–2717. 3 indexed citations
17.
Schwarzenböck, Sarah M., Michael Souvatzoglou, Jens Kurth, et al.. (2014). Comparison of [11C]Choline ([11C]CHO) and S(+)-β-Methyl-[11C]Choline ([11C]SMC) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model. Molecular Imaging and Biology. 17(2). 248–256. 2 indexed citations
18.
Meier, Reinhard, Rickmer Braren, Johanna Bussemer, et al.. (2014). Multimodality Multiparametric Imaging of Early Tumor Response to a Novel Antiangiogenic Therapy Based on Anticalins. PLoS ONE. 9(5). e94972–e94972. 14 indexed citations
19.
Souvatzoglou, Michael, Tibor Schuster, Roman Nawroth, et al.. (2013). Ansprechen auf eine Docetaxel-therapie im LNCaP-Prostata-karzinom-Xenograft-Mausmodell. Nuklearmedizin - NuclearMedicine. 52(4). 141–147. 6 indexed citations
20.
Schwarzenböck, Sarah M., et al.. (2012). FDG PET and PET/CT. Recent results in cancer research. 187. 351–369. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehran Jamali Breakdown of academic impact, for papers by Wolfgang Roll Breakdown of academic impact, for papers by Don Wilson Breakdown of academic impact, for papers by Johannes Schwenck Breakdown of academic impact, for papers by Christoph Straube Breakdown of academic impact, for papers by Kaisa Lehtiö Breakdown of academic impact, for papers by A. Fernandes Breakdown of academic impact, for papers by Vanessa Drendel Breakdown of academic impact, for papers by Hani Ashamalla Breakdown of academic impact, for papers by Jawana M. Lawhorn‐Crews
Rankless by CCL
2026